Neck News and Research

RSS

Medical case report on a traumatic tiger attack on a child

Exotic animals—wild animals unsuited to domestication—are increasingly housed in domestic settings. This sometimes leads to traumatic attacks suffered by owners or visitors. An example of a tiger attack on a child is described in the November issue of the Journal of Neurosurgery: Pediatrics.

21 Nov 2011

SAFC commences process validation activities for Oncolytics' REOLYSIN

Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.

21 Nov 2011

EU's FP7 programme provides €6M grant for Thyroid Hormone Replacement for Subclinical Hypo-Thyroidism Trial

Dr Patricia Kearney, Department of Epidemiology & Public Health, UCC is one of a group of researchers from European Universities who will participate in a new research project investigating current treatment practices for people who suffer from a mildly underactive thyroid gland.

21 Nov 2011

Understanding causes of TMJ dysfunction critical to a wellness and drugless approach to care

Understanding the relationship between proper function of the upper cervical spine, cranial bones and temporal-mandibular joint dysfunction (or TMJ dysfunction) is critical to a wellness and drugless approach to care.

19 Nov 2011

Scientists identify novel gene mutation that causes glioblastoma

Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant brain tumor.

18 Nov 2011

Researchers describe how brain handles spatial resolution

Everybody knows how to zoom in and out on an online map, to get the level of resolution you need to get you where you want to go. Now researchers have discovered a key mechanism that can act like a zoom button in the brain, by controlling the resolution of the brain's internal maps.

18 Nov 2011

Aurora kinase inhibitor may treat neuroendocrine prostate cancer

An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers.

17 Nov 2011

Coronary calcium scoring can determine risk of cardiac events

If your doctor says you have a negative stress test, or that your cholesterol or blood pressure are normal, how assured can you be that you're not likely to have a heart attack in the next seven to 10 years?

16 Nov 2011

Community-based cancer screening may increase awareness of smoking, reduce at-risk behaviors

Large, population specific community-based screening may increase awareness of the dangers of smoking and reduce at-risk behaviors, according to a new study in the November 2011 issue of Otolaryngology-Head and Neck Surgery.

16 Nov 2011

Scientists discover gene that helps protect body from squamous cell cancer

An extraordinary breakthrough in understanding what stops a common form of skin cancer from developing could make new cancer treatments and prevention available to the public in five years.

16 Nov 2011

Nearly one-fifth of Americans have severe hearing loss

Nearly a fifth of all Americans 12 years or older have hearing loss so severe that it may make communication difficult, according to a new study led by Johns Hopkins researchers and published in the Nov. 14 Archives of Internal Medicine.

15 Nov 2011

Positive results from Oncolytics REOLYSIN combination Phase 2 clinical trial for head and neck cancers

Oncolytics Biotech Inc. today announced that positive results from a Phase 2 clinical trial (REO 015) using intravenous administration of REOLYSIN in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

14 Nov 2011

Health supplement hope for child muscle disease

A health supplement used by bodybuilders could be the key to treating a life-threatening muscular dystrophy affecting hundreds of Australian children, new research shows.

14 Nov 2011

Children can have successful surgical repairs for hollow or sunken chest

Hollow or sunken chest, the most common congenital deformity of the chest wall affecting one in 300 to one in 400 children, is rarely life-threatening and virtually all children can have successful surgical repairs.

11 Nov 2011

NCCN ORP to evaluate clinical effectiveness of Boehringer Ingelheim's Afatinib in solid tumors

The National Comprehensive Cancer Network Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of Afatinib (BIBW 2992) in solid tumors, including breast, head and neck, and non-small cell lung (NSCL) cancers.

11 Nov 2011

First large scale trial of acupuncture for prevention of xerostomia

When given alongside radiation therapy for head and neck cancer, acupuncture has shown for the first time to reduce the debilitating side effect of xerostomia, according to new research from The University of Texas MD Anderson Cancer Center and Fudan University Shanghai Cancer Center.

11 Nov 2011

A range of studies highlight health care shortcomings

The New York Times reports that a $20 million government-supported study regarding an operation to prevent strokes was cut short when it found the surgery was not helping patients. Also, a Commonwealth Fund study concluded that the U.S. ranks near the bottom when compared to other countries on how it cares for the sickest patients. Lastly, the Health and Human Services inspector general finds a quarter of hospitalized Medicare patients received improper treatment.

10 Nov 2011

Pennsylvania Game Commission reminds hunters to avoid hypothermia

Pennsylvania Game Commission Hunter-Trapper Education Division Chief Keith A. Snyder is reminding hunters, trappers and other outdoors enthusiasts to plan well to avoid hypothermia.

10 Nov 2011

Idera third quarter net loss increases to $5.5 million

Idera Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2011. Idera is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like receptors (TLRs).

9 Nov 2011

First Edition: November 9, 2011

In today's headlines, reports on the latest developments related to the 'super committee's' deliberations, an appeals court issues a health law decision and results from yesterday's elections.

9 Nov 2011